Lorenzo's Oil (1992) Timeline Explained – Every Event in Order

When Lorenzo was diagnosed with ALD, doctors gave him a fatal prognosis with no effective treatments available. The medical community offered no solutions and even the support group for ALD patients discouraged experimental approaches. Augusto and Michaela refused to accept this fatalistic view, choosing to take matters into their own hands after realizing that no one else was actively working to save their son.

Foreshadowing: Earlier scenes show the family visiting medical specialists who offer no hope, setting up the parents' decision to research independently.

• Augusto Odone
• Michaela Odone
• ALD treatment
• parents quest

The breakthrough came at an international symposium on ALD that the Odones sponsored. During the conference, Dr. William B. Rizzo presented research showing that oleic acid could halt the accumulation of very long-chain fatty acids that cause ALD. The Odones immediately asked if this could help Lorenzo, and from there worked to obtain and refine the oil.

Foreshadowing: The Odones' decision to sponsor the symposium reflects their strategy of bringing scientists together to share research.

• oleic acid
• Dr. Rizzo
• symposium discovery
• fatty acids

Doctors and researchers viewed the Odones as laypeople with no scientific background attempting to solve a rare disease that professionals had been studying for years. The support group for ALD patients actively discouraged experimental treatments, fearing false hope. Additionally, the scientific process typically moves slowly with rigorous testing, while the Odones were pushing for rapid action to save their dying son.

Foreshadowing: Early scenes establish the rigid medical establishment through Professor Nikolais's initial skepticism.

• medical skepticism
• ALD research
• doctors
• support group

Lorenzo's Oil is a mixture of long-chain fatty acids (specifically oleic acid and erucic acid) that works by competitively inhibiting the absorption of harmful very long-chain fatty acids (VLCFAs) that accumulate in ALD patients. By introducing these specific oils into Lorenzo's diet, the treatment stops the progression of the disease and prevents further damage to the myelin sheath surrounding nerves.

• very long-chain fatty acids
• myelin
• oleic acid
• VLCFA

After learning about oleic acid from Dr. Rizzo's research, Michaela needed to find a company willing to produce the specific fatty acid mixture. Most pharmaceutical and chemical companies declined because the order was small, the request came from laypeople, and there was no established market for such a product. Her persistence in contacting over 100 firms worldwide eventually led her to Don Suddaby, an elderly British chemist willing to take on the challenge.

• Don Suddaby
• Michaela Odone
• pharmaceutical companies
• manufacturing

While Lorenzo's Oil successfully halted the progression of ALD and stabilized fatty acid levels in his blood, the damage already done to Lorenzo's nervous system could not be reversed quickly. The myelin sheath surrounding his nerves had been severely damaged, and nerve regeneration is extremely slow. Augusto then focused on finding ways to repair the myelin, knowing the oil alone could not undo existing neurological damage.

• nerve damage
• myelin repair
• slow recovery
• neurological damage

The film concludes by showing that Lorenzo's Oil became a groundbreaking treatment that helped many other ALD patients beyond Lorenzo. By preventing the accumulation of harmful fatty acids in their blood, the oil stopped the disease from progressing in other children diagnosed with ALD, giving them a chance at life that they would not have had otherwise.

• other patients
• ALD children
• treatment breakthrough
• legacy

By sponsoring and demanding an international symposium focused solely on ALD treatments, the Odones forced scientists who were typically scattered across different institutions to share their research in one place. This concentrated the collective scientific knowledge and led to Dr. Rizzo presenting his oleic acid findings, which otherwise might not have reached the Odones or been connected to practical treatment.

• scientific research
• conference
• collaboration
• ALD scientists

In the early 1990s, adrenoleukodystrophy was poorly understood with no effective treatments available. The standard prognosis for childhood-onset ALD was death within two years. The medical establishment had accepted this fatal outcome, and research into treatments was severely limited due to the disease's rarity and lack of funding.

• incurable disease
• fatal prognosis
• ALD history
• medical limitations

Augusto and Michaela were driven by parental love and an unwavering refusal to accept that nothing could be done. They believed that waiting passively for a cure while their son died was unacceptable. Their determination came from seeing Lorenzo as their child first and foremost, not as a patient with a terminal diagnosis that others had accepted.

• parental love
• determination
• refusal to give up
• motivation